Prediction Case File
YouTubeEvaluation Complete

Friends! In this video, I'm going to do a video on the Venezuela oil shock and stocks that could benefit from it.

5 extracted signals · 5 resolved · 0 still active

The Patient Investor profile imageThe Patient InvestorIndependent analyst profile
Source published
04 Jan 2026, 19:29 UTC
Recorded by Tahlil Plus
18 May 2026, 20:23 UTC
Video preview for Friends! In this video, I'm going to do a video on the Venezuela oil shock and stocks that could benefit from it.
Source overview

AI-generated source summary

The analysis suggests that crude oil prices may decline in the short term due to anticipated supply increases, but a long-term bullish outlook exists driven by factors like Venezuela's production potential and the Saudi Aramco's need to sustain dividends. The gold-to-oil ratio is highlighted as an indicator for accumulating oil stocks, with Occidental Petroleum (OXY) being favored due to its perceived undervaluation and catalysts for potential rerating. Refiners and integrated producers like Chevron (CVX), ExxonMobil (XOM), Valero (VLO), Phillips 66 (PSX), Marathon Petroleum (MPC), and Nordic American Tankers (NAT) are identified as potential beneficiaries.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Evaluation Complete
Signals
5
Extracted from this source
Open
0
Still being tracked
Successful
4
Resolved successfully
Failed
1
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
80%
5 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

  4. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  5. Market predictions extracted

    5 eligible signals linked to this case.

  6. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

Analyst snapshot

The Patient Investor

Platform-wide history, separate from this source evaluation.

Reliability
47.2
Tracked signals
327
Historical success
33.8%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail